Arrow Greentech-led Avery Pharma starts production at Sanand unit; Stock jumps 12%

Avery Pharmaceuticals is a wholly-owned subsidiary of Arrow Greentech.

September 12, 2022 9:16 IST | India Infoline News Service
Arrow Greentech Limited's Wholly Owned Subsidiary (WOS) Company Avery Pharmaceuticals Private Limited has started the commercial production of pharmaceutical & nutraceutical products in its manufacturing unit situated at Sanand, Ahmedabad on August 17, 2022.
As per the regulatory filing, this plant is dedicated for Mouth dissolving strip (MOS) manufacturing and Avery is a MOS manufacturing company to have signed an MOU at Vibrant Gujarat and has been appreciated by the Gujarat Government to launch Novel technology and raise standards of Drug delivery system.
Avery Pharma is approved with WHO-GMP followed by approvals of FDCA, FSSAI and ISO, GMP, GLP. The plant is approved to manufacture the Pharmaceuticals and Nutraceuticals range of products. The R&D of the plant is dedicated and fully equipped to undertake developments of novel technology including Sublingual films, buccal films, transdermal patches, veterinary films, combination films, Nanofilms, etc. 
The Plant houses a facility for in-house testing of the products. There is a separate provision for QC chemical and Micro testing of products and the production method follows semi-automatic and automatic processes, with high precision sensors for manufacture of quality products and entails minimal human intervention.

On Monday early morning trade, Arrow Greentech was trading at Rs91.50 per share higher by 12.68% on the BSE.

For feedback and suggestions, write to us at editorial@iifl.com

Invest wise with Expert advice



Open Demat Account

Invest wise with Expert advice

By continuing, I accept the Terms & Conditions and agree to receive updates on Whatsapp